← FDA DRUG APPROVALS

FDA NDA · NDA010423

LORFAN

Sponsor: ROCHE

APPLICATION
NDA010423
TYPE
NDA
ORIGINAL APPROVAL
1956-04-30
LATEST ACTION
2001-09-17
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

LORFANDiscontinued
LEVALLORPHAN TARTRATE 1MG/ML · INJECTABLE · INJECTION

Approval history

2001-09-17Labeling · Supplement 7AP
1983-05-11Labeling · Supplement 8AP
1983-04-19Labeling · Supplement 9AP
1956-04-30Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →